CN1204142C - 反基因V-erbB寡核苷酸及其应用 - Google Patents

反基因V-erbB寡核苷酸及其应用 Download PDF

Info

Publication number
CN1204142C
CN1204142C CNB001090232A CN00109023A CN1204142C CN 1204142 C CN1204142 C CN 1204142C CN B001090232 A CNB001090232 A CN B001090232A CN 00109023 A CN00109023 A CN 00109023A CN 1204142 C CN1204142 C CN 1204142C
Authority
CN
China
Prior art keywords
oligonucleotide
gene
mds
erbb
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001090232A
Other languages
English (en)
Chinese (zh)
Other versions
CN1326938A (zh
Inventor
冯宝章
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001090232A priority Critical patent/CN1204142C/zh
Priority to PCT/CN2001/000888 priority patent/WO2002020782A1/fr
Publication of CN1326938A publication Critical patent/CN1326938A/zh
Application granted granted Critical
Publication of CN1204142C publication Critical patent/CN1204142C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNB001090232A 2000-06-01 2000-06-01 反基因V-erbB寡核苷酸及其应用 Expired - Fee Related CN1204142C (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CNB001090232A CN1204142C (zh) 2000-06-01 2000-06-01 反基因V-erbB寡核苷酸及其应用
PCT/CN2001/000888 WO2002020782A1 (fr) 2000-06-01 2001-06-01 Oligonucleotides sens et antisens de v-erbb et ses applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001090232A CN1204142C (zh) 2000-06-01 2000-06-01 反基因V-erbB寡核苷酸及其应用

Publications (2)

Publication Number Publication Date
CN1326938A CN1326938A (zh) 2001-12-19
CN1204142C true CN1204142C (zh) 2005-06-01

Family

ID=4579371

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001090232A Expired - Fee Related CN1204142C (zh) 2000-06-01 2000-06-01 反基因V-erbB寡核苷酸及其应用

Country Status (2)

Country Link
CN (1) CN1204142C (fr)
WO (1) WO2002020782A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104928358A (zh) * 2015-02-13 2015-09-23 冯宝章 一种癌症早期基因诊断试剂盒及诊断方法
CN104928296A (zh) * 2015-02-13 2015-09-23 冯宝章 一种CpG寡核苷酸及其应用
CN104928359A (zh) * 2015-02-13 2015-09-23 冯宝章 一种癌干细胞的鉴定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838216B1 (en) * 1986-03-05 2010-11-23 The United States Of America, As Represented By The Department Of Health And Human Services Human gene related to but distinct from EGF receptor gene
US5183884A (en) * 1989-12-01 1993-02-02 United States Of America Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor

Also Published As

Publication number Publication date
WO2002020782A1 (fr) 2002-03-14
CN1326938A (zh) 2001-12-19

Similar Documents

Publication Publication Date Title
CN101152576A (zh) 防治阿尔茨海默病的药物
CN106511971A (zh) 神经调节蛋白在治疗外周神经损伤中的应用
CN107056887A (zh) 一种多肽及其在制备治疗和预防肿瘤的药物中的应用
CN108421035A (zh) 一种基于壳聚糖的纳米颗粒疫苗及其制备方法和应用
CN1204142C (zh) 反基因V-erbB寡核苷酸及其应用
CN1339973A (zh) 糖尿病性局部缺血疾病的基因治疗
CN1235026A (zh) 胎盘肽注射液的制备方法及其产品
CN1207022C (zh) 促进骨折愈合和骨关节损伤修复的药物组合物及其制备方法和应用
CN1839855A (zh) 人参皂苷f1的医药用途
CN1316972C (zh) 一种抗癌止痛制剂
CN1864666A (zh) 甲磺酸左氧氟沙星冻干粉针注射剂及其制备方法
CN1094052C (zh) 鹅血抗癌制剂
CN109718365B (zh) 重组人角质细胞生长因子的应用
CN1278676C (zh) 姜黄素注射制剂及其制备方法
CN1100550C (zh) 一种适用于各种癌症的中药组合物
CN1836651A (zh) 左旋舒必利注射剂的制备方法
US20210154159A1 (en) Uses of guanidine hydrochloride as a drug for treating cancers/tumors
Lu et al. High-frequency electrical stimulation reduced hyperalgesia and the activation of the Myd88 and NFκB pathways in chronic constriction injury of sciatic nerve-induced neuropathic pain mice
CN112516150B (zh) 雷公藤三萜酸在制备防治白斑综合征病毒药物的应用
WO2017218638A1 (fr) Méthodes de traitement de sujets souffrant de leucémie aiguë myéloïde avec des nanoparticules de mir-150 ciblées sur un ligand flt3
CN111574590B (zh) 一种具有抗肿瘤功能的多肽及其应用
CN1493301A (zh) 6-甲氧基双脱氧鸟苷在制备抗乙肝药物中的应用
CN106236767B (zh) cGAMP在制备防治缺血性脑血管疾病药物中的应用
Takeuchi et al. AB0492 ANEMIA IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK INHIBITORS
CN118078776A (zh) 一种共递送多核酸药物的聚合物囊泡及其制备方法与治疗ra的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050601

Termination date: 20150601

EXPY Termination of patent right or utility model